Would you give PMRT to a young woman with a T1-2 breast cancer with a micromet on SLNB?
What factors would help aid your decision?
Answer from: Radiation Oncologist at Community Practice
No great data as far as I know. In general, I treat micromets as ~pN0. @Reshma Jagsi and colleagues reported on LRR rates and prognostic factors for failure in pN0 patients treated with mastectomy to identify subsets of node-negative patients with sufficiently high risk of LRR who might benefit...
Answer from: Radiation Oncologist at Community Practice
The data in this regard is limited or non existent.In one randomized study the recurrence in locoregional area for micromets and no additional dissection was very low. But only 10 percent in that study had mastectomy and most had t1 disease and favorable phenotypehttps://www.ncbi.nlm.nih.gov/pubmed/...